TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview ‘Dengue Fever - Pipeline Review, H1 2016’, provides an overview of the Dengue Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dengue Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Read More At: http://www.researchbeam.com/dengue-fever-pipeline-review-h1-2016-market
Report Overview Scope • The report provides a snapshot of the global therapeutic landscape of Dengue Fever • The report reviews pipeline therapeutics for Dengue Fever by companies and universities/research institutes based on information derived from company and industryspecific sources • The report reviews key players involved Dengue Fever therapeutics and enlists all their projects • The report summarizes all the dormant and discontinued pipeline projects • The report reviews latest news related to pipeline therapeutics for Dengue Fever
Reasons to buy • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage • dentify and understand important and diverse types of therapeutics under development for Dengue Fever • Identify potential new clients or partners in the target demographic • Develop strategic initiatives by understanding the focus areas of leading companies Read More At: http://www.researchbeam.com/dengue-fever-pipeline-review-h1-2016-market
Table of Content List of Figures Number of Products under Development for Dengue Fever, H1 2016 17 Number of Products under Development for Dengue Fever - Comparative Analysis, H1 2016 18 Number of Products under Development by Companies, H1 2016 19 Number of Products under Investigation by Universities/Institutes, H1 2016 22 Comparative Analysis by Late Stage Development, H1 2016 24 Comparative Analysis by Clinical Stage Development, H1 2016 25 Comparative Analysis by Early Stage Products, H1 2016 26 Assessment by Monotherapy Products, H1 2016 69 Number of Products by Top 10 Targets, H1 2016 70 Number of Products by Stage and Top 10 Targets, H1 2016 70 Number of Products by Top 10 Mechanism of Actions, H1 2016 72 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 72 Number of Products by Routes of Administration, H1 2016 74 Number of Products by Stage and Routes of Administration, H1 2016 74 Number of Products by Top 10 Molecule Types, H1 2016 76 Number of Products by Stage and Top 10 Molecule Types, H1 2016 76 Enquire At : http://www.researchbeam.com/dengue-fever-pipeline-review-h1-2016-market/enquireabout-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/dengue-fever-pipeline-review-h1-2016market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States